Unresectable Renal Pelvis Urothelial Carcinoma
5 clinical trials · Condition
◉ Watch Unresectable Renal Pelvis Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy (NCT03935347) | Roswell Park Cancer Institute | 2019-06-20 |
| Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma (NCT03513952) | National Cancer Institute (NCI) | 2019-06-05 |
| Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer (NCT03237780) | National Cancer Institute (NCI) | 2018-07-20 |
Track Unresectable Renal Pelvis Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.